🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Hemorrhagic Disorders

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site📍 London Hemab ApS · Tests: Sutacimig, Sutacimig A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma NCT07284758Phase 260 sites📍 Huntsville📍 Phoenix📍 Scottsdale C4 Therapeutics, Inc. · Tests: Cemsidomide, Dexamethasone An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A NCT07088458n/a12 sites📍 Loma Linda📍 New Brunswick📍 Many Locations Bayer · Tests: Damoctocog alfa pegol (Jivi, Bay94-9027) Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance NCT06483100Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Elrantamab, clonoSEQ Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma NCT05896228Phase 21 site📍 Miami Benjamin T Diamond, MD · Tests: Iberdomide, Carfilzomib, Daratumumab, Dexamethasone, Acetaminophen In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET NCT05093335EARLY Phase 11 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: [68Ga]-Pentixafor Universal CAR-T Cell Therapy for MM NCT07248176NA1 site📍 Shanghai Bioray Laboratories · Tests: Targeted BCMA Gene-Modified Allogeneic Chimeric Antigen Receptor T-Cell Injection CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study NCT06644625n/a1 site📍 Charlotte Wake Forest University Health Sciences · Tests: Blood draw for the laboratory assessment Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy NCT05646576NA1 site📍 Boston Massachusetts General Hospital · Tests: Palliative Care, Usual Care Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects NCT07358013n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Blood sample collection for VWF measurements in plasma, Blood sample collection for ECFC isolation and characterization… A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients NCT05641610Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: ZS801 The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites📍 Beijing📍 Beijing📍 Beijing Peking University People's Hospital · Tests: Teriflunomide, Dexamethasone Bleeding Disorder of Unknown Cause in the Netherlands NCT07454161n/a8 sites📍 Nijmegen📍 Maastricht📍 Veldhoven Maastricht University Medical Center Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE) NCT04991103Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: DaraVRD/DaraVCD Manual Therapy in Hemophilic Arthropathy of the Ankle NCT06816056NA1 site📍 Murcia Investigación en Hemofilia y Fisioterapia · Tests: Manual Therapy, Placebo A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease NCT06998524Phase 329 sites📍 Sacramento📍 Gainesville📍 Lexington Hoffmann-La Roche · Tests: Emicizumab, von Willebrand Factor (VWF) Concentrates, Factor VIII (FVIII) Concentrates, von Willebrand Factor (VWF) and… A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments NCT05714839Phase 1, Phase 244 sites📍 Bullhead City📍 Los Angeles📍 Pembroke Pines GlaxoSmithKline · Tests: Belantamab, Belantamab mafodotin, Pomalidomide, Dexamethasone Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma NCT07236502NA2 sites📍 Maywood📍 Milwaukee Medical College of Wisconsin · Tests: Immediate intervention, Waitlist A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma NCT07760454Phase 1, Phase 22 sites📍 Suzhou📍 Shanghai UCARsgen Biotech Limited · Tests: CT0596 Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway in Multiple Myeloma NCT04234022n/a1 site📍 Wolverhampton The Royal Wolverhampton Hospitals NHS Trust · Tests: Zn-DDC, Lanalidomide with Zn-DDC, Pomalidomide with Zn-DDC Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma NCT06245629n/a1 site📍 Uppsala Uppsala University · Tests: Bortezomib-bendamustine-melphalan Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study NCT05916469n/a9 sites📍 Palo Alto📍 Aurora📍 Atlanta Oregon Health and Science University · Tests: Levonorgestrel Intrauterine System, Norethindrone Acetate A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms NCT06034002Phase 113 sites📍 Duarte📍 Palo Alto📍 Miami Incyte Corporation · Tests: INCA033989, Ruxolitinib A Trial of Selinexor, Ruxolitinib and Methylprednisolone NCT06225310Phase 11 site📍 West Hollywood Oncotherapeutics · Tests: Selinexor, Ruxolitinib, Methylprednisolone Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia NCT05931718n/a1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: cytokine essays, NGS, Fecal microbiome, Erythropoietin, Luspatercept Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia NCT05640102n/a8 sites📍 Huntsville📍 Mobile📍 Duarte BeiGene · Tests: Zanubrutinib Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma NCT07200102Phase 11 site📍 St Louis Washington University School of Medicine · Tests: Selinexor A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252Phase 11 site📍 Atlanta OriCell Therapeutics Co., Ltd. · Tests: OriCAR-017 A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) NCT07059000Phase 328 sites📍 Los Angeles📍 Shirley📍 Greenville Kedrion S.p.A. · Tests: Kedrion IVIG 10%
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy